Results 211 to 220 of about 3,094,165 (247)
Abstract Infection is a known cause of abdominal aortic aneurysm (AAA), and matrix metalloproteases‐2 (MMP‐2) secreted by vascular smooth muscle cells (SMCs) plays a key role in the structural disruption of the middle layer of the arteries during AAA progression.
Yi‐Wen Lin +6 more
wiley +1 more source
Prevalence of Masked and White-Coat Hypertension in Pre-Hypertensive and Stage 1 Hypertensive patients with the use of TeleMRPA. [PDF]
Barroso WKS +7 more
europepmc +1 more source
Modified pedicle‐guided fixation technique for iliosacral screw placement in prone position reduces operation time and radiation exposure as conventional two‐dimensional fluoroscopy was enough to identify safe insertion corridors. Prone position is also advantageous when dealing with obese patients and concomitant spinal injuries.
Ben‐Mao Liu +5 more
wiley +1 more source
White-Coat Hypertension: A True Cardiovascular Risk?: Commentary on "The impact of white-coat hypertension on cardiac mechanics". [PDF]
Mani A.
europepmc +1 more source
Advanced Conduction Disease After Incident Heart Failure in Myotonic Dystrophy Type 1
Central Figure. Advanced Conduction Disease After Incident HF in Myotonic Dystrophy Type 1. ABSTRACT Background Myotonic dystrophy type 1 (DM1) is associated with progressive cardiac conduction disease, heart failure (HF) and increased mortality. However, the association of incident HF with conduction disease and survival in DM1 is not well defined ...
Isadora Guarino +3 more
wiley +1 more source
Lifestyle Approaches to White Coat Hypertension. [PDF]
Hubkova T.
europepmc +1 more source
White-coat hypertension: management and adherence to guidelines by European and Canadian GPs. A cross-sectional clinical vignette study. [PDF]
Humbert X +4 more
europepmc +1 more source
Novel and emerging antimicrobial strategies in the management of oral infections
Abstract Background Antibiotics marked a pivotal turning point in human civilization, enhancing social interactions and extending human life expectancy. In addition to their success in treating systemic infectious diseases, they have significantly improved periodontal treatment outcomes as an adjunct therapy.
Ozge Unlu, Nil Yakar, Alpdogan Kantarci
wiley +1 more source
Abstract Background Periodontal clinical trials commonly use surrogate end points (e.g., probing pocket depth [PPD], clinical attachment level [CAL], bleeding on probing [BoP], and composite scores such as the Periodontal Risk Score [PRS]) for efficiency, yet tooth loss, treatment burden/cost, and re‐treatment are the definitive patient‐relevant ...
Muhammad H. A. Saleh +7 more
wiley +1 more source

